QCI Asset Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

QCI Asset Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-485	Closed	-$42K	–	515
2020 Q1	$42K	Hold	485	–	–	﹤0.01%	251
2019 Q4	$51K	Buy	485 +75	+18%	+$8.41K	﹤0.01%	254
2019 Q3	$47K	Buy	410 +59	+17%	+$8.96K	﹤0.01%	263
2019 Q2	$61K	Sell	351 -310	-47%	-$53.6K	0.01%	253
2019 Q1	$111K	Hold	661	–	–	0.01%	175
2018 Q4	$64K	Buy	661 +306	+86%	+$40.1K	0.01%	227
2018 Q3	$61K	Buy	+355	New	+$51.2K	0.01%	254

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

QCI Asset Management's GWPH Position: Q2 2020 in Review

QCI Asset Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2020, closing a stake of 485 shares — an estimated $42K sold.

QCI Asset Management first reported a position in GWPH in Q3 2018 and held it in 7 quarters. The position peaked at $111K in Q1 2019. 299 funds tracked by Wall St. Rank hold GWPH as of Q2 2020.

QCI Asset Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2020 after selling out during the quarter.
QCI Asset Management sold 485 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2020, an estimated $42K.
QCI Asset Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2018 and held it in 7 quarters.
QCI Asset Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $111K in Q1 2019.
299 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2020.

Based on QCI Asset Management's 13F filing for Q2 2020, filed 31 Jul 2020.